Elizabeth Drake
Family · Winter Garden, FLNPI 1215451190
Payments from drug & device makers
Across 79 payments — averaging $73.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Draeger Medical Systems, Inc$4K
- Novo Nordisk$726
- Lilly USA, LLC$160
- AbbVie$154
- Johnson & Johnson$108
- Sanofi-aventis U.S. LLC$88
- plus $841 from 21 others
What the payments were for
- Speaking & faculty fees$3,72064%
- Food & beverage$2,07936%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Draeger Medical Systems, Inc | 3 | $3,720 |
| Novo Nordisk | 18 | $726 |
| Lilly USA, LLC | 8 | $160 |
| AbbVie | 7 | $154 |
| Johnson & Johnson | 1 | $108 |
| Sanofi-aventis U.S. LLC | 4 | $88 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| Tandem Diabetes Care, Inc. | 3 | $75 |
| Amgen | 4 | $75 |
| Bayer | 3 | $72 |
| Amneal Pharmaceuticals LLC | 3 | $64 |
| Madrigal Pharmaceuticals | 2 | $63 |
| Cequr Corporation | 1 | $51 |
| Almatica Pharma LLC | 2 | $47 |
| Recordati_rare_diseases_inc. | 2 | $47 |
| Exact Sciences | 2 | $37 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Sequel Med Tech, LLC | 1 | $27 |
| Corcept Therapeutics | 1 | $26 |
| Abbott | 1 | $25 |
| BETA Bionics, Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
| Boehringer Ingelheim | 1 | $18 |
| Novartis | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BABYLOG VN500$1,485
- BIRTHING ROOM WARMER$1,485
- Babyroo TN300 Infant Radiant Warmer$750
- Ozempic$112
- DARZALEX$108
How this compares
$5,799 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 96 | $147,951 |
| OzempicSemaglutide | 67 | $88,250 |
| JardianceEmpagliflozin | 66 | $87,491 |
| FarxigaDapagliflozin Propanediol | 28 | $35,665 |
| TrulicityDulaglutide | 11 | $29,045 |
| RybelsusSemaglutide | 16 | $26,598 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 19 | $19,554 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $13,364 |
| Humalog Kwikpen U-100Insulin Lispro | 11 | $6,206 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $5,024 |
| SynthroidLevothyroxine Sodium | 41 | $3,310 |
| Ultra-Fine Short Pen NeedlePen Needle, Diabetic | 11 | $1,221 |
| Levothyroxine Sodium | 76 | $703 |
| Rosuvastatin Calcium | 26 | $540 |
| Metformin Hcl ErMetformin Hcl | 45 | $385 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $160 | $176,995107 claims |
| Novo NordiskOzempic, Rybelsus | $726 | $114,84983 claims |
| Boehringer IngelheimJardiance | $18 | $87,49166 claims |
| AbbVieSynthroid | $154 | $3,31041 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $64 | $70376 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Winter Garden
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.